Anhui Province Natural Gas Development (603689.SH) plans to acquire a 51% stake in for 174 million yuan.
Wanhua Gas (603689.SH) announced that the company plans to acquire 51% of the equity of its affiliate, Anhui Energy Group Co., Ltd. (referred to as "Wannan Group"), wholly owned subsidiary Anhui Wanan Poly Smart Energy Co., Ltd. (referred to as "Poly Energy Company") for a total consideration of 174 million yuan using its own funds. Upon completion of the acquisition, the company will hold 51% equity in Poly Energy Company, which will be a controlled subsidiary of the company, while Wannan Group will still hold 49% equity in Poly Energy Company.
Anhui Province Natural Gas Development (603689.SH) announced that the company plans to use its own funds of 174 million yuan to acquire a 51% stake in Anhui Waneng Polynergy Company Limited (referred to as Polynergy), a wholly-owned subsidiary of its related party Anhui Energy Group Co., Ltd. (referred to as Waneng Group). After the acquisition is completed, the company will hold a 51% stake in Polynergy, making it a controlling subsidiary, while Waneng Group will retain a 49% stake in the company.
Subsequently, the company will jointly increase its capital with Waneng Group by 210 million yuan based on their shareholding ratio, with the company contributing 107 million yuan. The total amount for this acquisition and capital increase by the company will be 281 million yuan. This acquisition is driven by the companys need for business expansion, facilitating the companys acceleration in establishing a network of comprehensive energy terminals, improving the development layout of the entire industry chain, and further positioning the company as a high-quality comprehensive energy service provider.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276): HRS-1597 tablets have obtained the Drug Clinical Trial Approval Notice.

Semiconductor Manufacturing International Corporation (00981) issued 1,000 shares according to the equity plan.

YOUZAN (06051) spent HKD 1.0693 million to repurchase 900,000 shares on September 7.
Jiangsu Hengrui Pharmaceuticals (01276): HRS-1597 tablets have obtained the Drug Clinical Trial Approval Notice.

Semiconductor Manufacturing International Corporation (00981) issued 1,000 shares according to the equity plan.

YOUZAN (06051) spent HKD 1.0693 million to repurchase 900,000 shares on September 7.

RECOMMEND





